Inventor · disambiguated record
Kevin P. Anderson
Also filed as: ANDERSON KEVIN · ANDERSON KEVIN P · ECKER DAVID J
17 granted patents·7 pending applications·1,354 citations·filing 1991–2011
96Inventor score
Top patents by PatentIndex Score
24 records- 0196US5789573AAntisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2ISIS PHARMACEUTICALS INC·Filed 1996·Granted Aug 4, 1998·262 cites·4 claims
- 0295US7067497B2Modulation of telomere length by oligonucleotides having a G-core sequenceISIS PHARMACEUTICALS INC·Filed 2002·Granted Jun 27, 2006·57 cites·16 claims
- 0395US6174868B1Compositions and methods for treatment of hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1997·Granted Jan 16, 2001·141 cites·11 claims
- 0492US5952490AOligonucleotides having a conserved G4 core sequenceISIS PHARMACEUTICALS INC·Filed 1993·Granted Sep 14, 1999·69 cites·27 claims
- 0590US6608191B1Compositions and methods for treatment of hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 2000·Granted Aug 19, 2003·34 cites·4 claims
- 0690US6423489B1Compositions and methods for treatment of Hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1995·Granted Jul 23, 2002·120 cites·7 claims
- 0790US5514577AOligonucleotide therapies for modulating the effects of herpes virusesISIS PHARMACEUTICALS INC·Filed 1993·Granted May 7, 1996·153 cites·2 claims
- 0887US6284458B1Compositions and methods for treatment of hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1993·Granted Sep 4, 2001·87 cites·6 claims
- 0986US6995146B2Compositions and methods for treatment of hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 2001·Granted Feb 7, 2006·26 cites·8 claims
- 1083US6391542B1Compositions and methods for treatment of Hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1996·Granted May 21, 2002·95 cites·8 claims
- 1183US5591720AOligonucleotides for modulating the effects of cytomegalovirus infectionsISIS PHARMACEUTICALS INC·Filed 1991·Granted Jan 7, 1997·83 cites·2 claims
- 1281US6433159B1Compositions and methods for treatment of Hepatitis C virus associated diseasesISIS PHARMACEUTICALS INC·Filed 1997·Granted Aug 13, 2002·67 cites·1 claims
- 1380US5442049AOligonucleotides for modulating the effects of cytomegalovirus infectionsISIS PHARMACEUTICALS INC·Filed 1993·Granted Aug 15, 1995·57 cites·1 claims
- 1479US5985662AAntisense inhibition of hepatitis B virus replicationISIS PHARMACEUTICALS INC·Filed 1995·Granted Nov 16, 1999·47 cites·2 claims
- 1572US5698391AMethods for synthetic unrandomization of oligomer fragmentsISIS PHARMACEUTICALS INC·Filed 1994·Granted Dec 16, 1997·36 cites·80 claims
- 1659US2007015723A1Antiviral oligonucleotides having a conserved G4 core sequenceISIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1755US2005261228A1Antisense modulation of interleukin 12 P35 subunit expressionBENNETT C F·Filed 2005·Application pending·0 cites
- 1853US2011124715A1Antiviral Oligonucleotides Having a Conserved G4 Core SequenceHANECAK RONNIE C·Filed 2010·Application pending·0 cites
- 1953US2004033978A1Compositions and methods for treatment of Hepatitis C virus-associated diseasesFiled 2003·Application pending·0 cites
- 2049US6153595AComposition and method for treatment of CMV infectionsISIS PHARMACEUTICALS INC·Filed 1997·Granted Nov 28, 2000·8 cites·21 claims
- 2148US2004049021A1Compositions and mehtods for treatment of Hepatitis C virus-associated diseasesFiled 2003·Application pending·0 cites
- 2246US5672472ASynthetic unrandomization of oligomer fragmentsISIS PHARMACEUTICALS INC·Filed 1992·Granted Sep 30, 1997·12 cites·64 claims
- 2344US2002052331A1Compositions and methods for antisense inhibition of protein translationFiled 2001·Application pending·0 cites
- 2428US2012035320A1Polyacridine nucleic acid delivery peptide complexesRICE KEVIN G·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin P. Anderson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →